Autologous tumor-infiltrating lymphocytes (HS-IT101) with low-dose lymphodepletion and IL-2 infusion for the treatment of advanced solid tumors: A phase I clinical trial. This is an ASCO Meeting ...
Complex structures continue to pose significant challenges for comprehensive characterization of innovative therapeutics. Join this webinar to learn how to utilize advanced mass spectrometry ...
The melting of materials seems like a simple phenomenon. However, when their thickness is reduced to just a few atoms, established rules waver. In this two-dimensional mode, new states emerge between ...
A phase I study to evaluate the safety and effectiveness of neoantigen-based personalized dendritic cell vaccine in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results